Two hundred twenty group D streptococci isolated from 1953 to 1954 from patients in the Washington, D.C., area were characterized. All were susceptible to ampicillin, vancomycin, and gentamicin; none produced ␤-lactamase activity. High-level resistance to streptomycin was expressed by 117 strains, and 2 strains were resistant to >8 g of chloramphenicol per ml. Three isolates were resistant to both erythromycin and lincomycin, and DNA from these hybridized to an ermAM probe. Of 118 strains resistant to tetracycline and minocycline, genomic DNA from 63 was examined for homology to tet(M), tet(O), and tet(S). DNA from 20 strains hybridized to tet(M), DNA from 37 strains hybridized to tet(S), and DNA from none of the strains hybridized to tet(O).
Characterization of group D streptococcal isolates.
A study was begun of the antibiotic susceptibilities of streptococcal isolates collected between 1930 and the late 1970s by Roger M. Cole (retired chief of the Laboratory of Streptococcal Diseases, National Institute of Allergy and Infectious Diseases). Only 247 isolates in the collection were classified as group D streptococci, and all had been obtained between 1953 and 1954 from members of the staffs of Georgetown University Hospital (GH; n ϭ 101), the National Institutes of Health Clinical Center Hospital (CC; n ϭ 52), or outpatient and referral services (OP; n ϭ 67). The 220 of these that remained cultivable were identified as described by Facklam and Collins (6) as Enterococcus spp. by their ability to grow in the presence of 6.5% NaCl, to hydrolyze bile esculin, and to have a positive result with the PYR hydrolysis test. The majority were classified as E. faecalis (89%); 8 and 3% were E. faecium and E. raffinosus, respectively. The strains were isolated from a variety of sources including urinary, respiratory, gastrointestinal, or genital tracts; the bloodstream; and skin. Seventy-three percent of the hospital isolates and 58% of the OP isolates contained between one and five detectable species of plasmid DNA, determined as described by Anderson and McKay (1), with modifications as described previously (8) .
Antibiotic susceptibilities of enterococcal strains. The susceptibilities of the isolates to various antibiotics were determined by the agar dilution method, and definitions of resistance were based on current standards of the National Committee for Clinical Laboratory Standards (11) . The MIC was defined as the lowest concentration of an antibiotic that completely inhibited visible growth and was determined after incubation for 18 h and again after 48 h for the aminoglycosides. The numbers of isolates resistant to each of the antibiotics tested are presented in Table 1 . None of the isolates were resistant to ampicillin, gentamicin, or vancomycin, and none expressed detectable ␤-lactamase activity when tested with cefinase discs (BBL Microbiology Systems, Cockeysville, Md.). More than half of the isolates expressed high-level resistance to streptomycin, and nearly 60% were resistant to tetracycline. Ninety-four percent of the tetracycline-resistant strains were also resistant to minocycline. Three of the six erythromycin-resistant strains also expressed resistance to lincomycin, suggesting a macrolide-lincosamide-streptogramin (MLS) resistance phenotype (17) . Three strains were resistant to lincomycin but not to erythromycin. The MIC of chloramphenicol was greater than 8 g/ml for two of the isolates. Seventy-nine percent of the hospital isolates and 33% of the isolates from outpatients expressed resistance to at least one of the antibiotics tested. Multiple resistance patterns were observed, with resistance to streptomycin, tetracycline, and minocycline being the most common (56% of the resistant strains). Three strains expressing this pattern also were resistant to erythromycin and lincomycin.
Genetic determinants encoding tetracycline-minocycline and MLS resistance. The presence in enterococci of three genetic determinants which encode resistance to tetracycline and minocycline, tet(M) (3), tet(O) (13) , and tet(S) (5), has been reported previously. DNA fragments internal to a structural gene representative of each of these determinants were used as probes in hybridization experiments to assess which, if any, would account for the tetracycline-minocycline resistance phenotypes observed in selected isolates. Total cell DNA was obtained from each of the 62 tetracycline-minocycline-resistant isolates and 1 isolate from GH resistant only to tetracycline. The DNA was prepared as described by Anderson and McKay (1) , except that the 3.0 M NaCl and 2.0 M Tris-HCl steps used to enrich for plasmids were eliminated. Undigested DNA sam-ples (1 to 2 g) were transferred to nitrocellulose filters by using a slot blot apparatus (Milliblot Systems; Millipore, Bedford, Mass.) as described previously (12) . A 1.8-kb HindIIIKpnI fragment containing most of the tet(M) gene from Tn916 (2) was purified from an agarose gel with an Elu-Quik kit (Schleicher & Schuell, Keene, N.H.) and was used as a tet(M) probe. A 1.9-kb HincII DNA fragment from pDL421 (10) containing the tet(O) structural gene was purified from an agarose gel as described above. A 590-bp DNA fragment internal to the tet(S) structural gene was amplified by PCR from total genomic DNA purified from a tetracycline-resistant isolate of Listeria monocytogenes with the oligonucleotide primers described by Charpentier et al. (4) . This fragment also was purified from an agarose gel. Probes were labeled with [ 32 P]dATP by nick translation (9) or nonisotopically by using the Renaissance Labeling and Chemiluminescence Detection Random Primer Fluorescein dUTP Labeling Kit from Dupont Research Products (Boston, Mass.). Hybridization conditions were as described previously (9) . The results of all hybridizations are summarized in Table 2 . DNA from 20 of the tetracycline-minocycline-resistant strains hybridized to the tet(M) probe, whereas DNA from 36 strains expressing the tetracycline-minocycline resistance phenotype and 1 isolate resistant to tetracycline only hybridized to the tet(S) probe. None of the DNA preparations from any of the strains tested hybridized to the tet(O) probe. DNA from six of the isolates did not hybridize to any of the probes.
Three isolates were resistant to erythromycin and lincomycin, three were resistant to erythromycin only, and three were resistant to lincomycin only. DNA from each of these strains was digested with HindIII, and the fragments were separated by agarose gel electrophoresis. A Southern blot (14) was prepared from the gel and hybridized with a 1.5-kb ClaI DNA fragment internal to the ermAM gene from pJH1 (8) . A single DNA fragment from each of the strains resistant to both erythromycin and lincomycin hybridized to the probe (data not shown). None of the DNA from the strains resistant to only one of these antibiotics hybridized to the probe. Finland and associates (7, 15, 16) reported the results of studies on the antibiotic susceptibilities of 187 enterococci isolated from patients at Boston City Hospital between 1953 and 1954. Nearly the same percentages of isolates that were resistant to streptomycin and tetracycline were seen in the Washington, D.C., strains described here. However, although the tetracycline MICs for 55% of the Boston isolates were greater than 32 g/ml, indicative of a tetracycline-minocycline resistance phenotype, these isolates were not tested with minocycline. Two notable differences between the Washington, D.C., area isolates and the Boston strains are their susceptibilities to chloramphenicol and erythromycin. Whereas only 1 and 3% of the former isolates were resistant to chloramphenicol (MICs ϭ 16 to 32 g/ml) and erythromycin (MICs ϭ 4 to 256 g/ml), respectively, for 96% of the Boston isolates chloramphenicol MICs were 16 g/ml or greater, and nearly 25% were resistant to erythromycin. The Boston isolates were not tested with lincomycin, so there is no indication as to how many of the erythromycin-resistant isolates were likely to be carrying an MLS resistance determinant. The Boston isolates from 1953 and 1954 also were not tested for their susceptibilities to vancomycin, gentamicin, or ampicillin, although the MIC of penicillin for 5% of those strains was greater than 8 g/ml. Finally, since genes for tetracycline-minocycline and MLS resistance had not been cloned and characterized at the time of the studies conducted by Finland and associates, it was not possible to identify the genetic determinants responsible for these resistance phenotypes.
(This work was presented at the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, Fla., 4 to 7 October 1994 [1a] .)
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